|
Phenotype submission - Primary adenocarcinoma of colon or rectum, MSI-H or dMMR
|
|
1
|
61
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon or rectum, MSI-H or dMMR, oncological treatment no surgery
|
|
1
|
70
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon or rectum, MSI-H or dMMR, surgical treatment
|
|
1
|
75
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, no surgery or oncological treatment
|
|
1
|
70
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no curative surgery
|
|
1
|
68
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR, treated with curative intended surgery
|
|
1
|
69
|
September 18, 2023
|
|
Phenotype submission: Primary adenocarcinoma of the colon or rectum, MSI-L, MSI-indeterminate, MSS or pMMR
|
|
1
|
73
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, no curative intended surgery and oncological treatment
|
|
1
|
70
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, no curative intended surgery
|
|
1
|
73
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma cancer reciving surgical treatment
|
|
1
|
77
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of the colon or rectum, MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
54
|
September 18, 2023
|
|
Phenotype submission - local recurrence following colorectal cancer
|
|
1
|
69
|
September 18, 2023
|
|
Phenotype submission - Postoperative hemorrhage
|
|
1
|
78
|
September 18, 2023
|
|
Phenotype submission - Perioperative aspiration
|
|
1
|
73
|
September 18, 2023
|
|
Phenotype submission - Anastomotic leak or dehiscence following colorectal surgery
|
|
1
|
74
|
September 18, 2023
|
|
Phenotype submission - Fascial dehiscence and evisceration
|
|
1
|
101
|
September 18, 2023
|
|
Phenotype submission - Acute Respiratory Failure
|
|
1
|
77
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon or rectum
|
|
1
|
62
|
September 18, 2023
|
|
Phenotype submission - Radiotherapy against colorectal cancer
|
|
1
|
70
|
September 18, 2023
|
|
Phenotype submission - Potential curative surgery for colorectal cancer
|
|
1
|
70
|
September 18, 2023
|
|
Phenotype submission - Antineoplastic drugs against colorectal cancer
|
|
1
|
66
|
September 18, 2023
|
|
Phenotype Submission - Plaque Psoriasis
|
|
2
|
300
|
September 16, 2023
|
|
Phenotype Submission - Essential Hypertension
|
|
4
|
108
|
September 16, 2023
|
|
Phenotype Submission - Left Heart Failure
|
|
2
|
94
|
September 16, 2023
|
|
Phenotype Submission - Multiple Myeloma
|
|
1
|
65
|
September 16, 2023
|
|
Phenotype Submission - Colorectal Cancer
|
|
1
|
73
|
September 16, 2023
|
|
Phenotype Submission - Breast Cancer
|
|
1
|
64
|
September 16, 2023
|
|
Phenotype Submission - Glioblastoma multiforme
|
|
1
|
62
|
September 16, 2023
|
|
Phenotype Submission - Non-small cell lung cancer
|
|
1
|
86
|
September 16, 2023
|
|
Phenotype Submission - Skin Burns
|
|
1
|
89
|
September 16, 2023
|
